BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/20/2014 9:24:00 PM | Browse: 1754 | Download: 2000
 |
Received |
|
2014-05-28 12:07 |
 |
Peer-Review Started |
|
2014-05-28 21:09 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-07-17 15:03 |
 |
Revised |
|
2014-08-27 10:51 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-11-10 11:41 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-11-19 09:16 |
 |
Articles in Press |
|
2014-11-19 09:43 |
 |
Edit the Manuscript by Language Editor |
|
2014-11-20 18:16 |
 |
Typeset the Manuscript |
|
2014-12-11 15:32 |
 |
Publish the Manuscript Online |
|
2014-12-20 19:42 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ting-Ting Li, Shuji Ogino and Zhi Rong Qian |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| United States National Institute of Health (NIH) |
P01 CA87969 (to SE Hankinson) |
| United States National Institute of Health (NIH) |
UM1 CA167552 |
| United States National Institute of Health (NIH) |
P01 CA55075 (to WC Willett) |
| United States National Institute of Health (NIH) |
R01 CA137178 (to AT Chan) |
| United States National Institute of Health (NIH) |
P50 CA127003 (to CS Fuchs) |
| United States National Institute of Health (NIH) |
R01 CA151993 (to S Ogino) |
| Bennett Family Fund for Targeted Therapies Research |
|
| Entertainment Industry Foundation through National Colorectal Cancer Research Alliance |
|
|
| Corresponding Author |
Zhi-Rong Qian, MD, PhD, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave., Room M420, Boston, MA 02215, United States. zhirong_qian@dfci.harvard.edu |
| Key Words |
Toll-like receptor; Colorectal cancer; Carcinogenesis; Prognosis; Cancer therapy |
| Core Tip |
Toll-like receptors (TLRs) are innate immune sensors which can recognize inflammatory mediators. TLRs have been shown to mediate inflammatory response and maintain epithelial barrier homeostasis. Inflammation is a risk factor for many cancers including colorectal cancer (CRC). The key molecules involved in inflammation-driven carcinogenesis include TLRs. In this paper, we reviewed TLR signaling in CRC from carcinogenesis to cancer therapy.
|
| Publish Date |
2014-12-20 19:42 |
| Citation |
Li TT, Ogino S, Qian ZR. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy. World J Gastroenterol 2014; 20(47): 17699-17708
|
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i47/17699.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i47.17699 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.